AI-generated summary
The authors studied ten patients with dry age-related macular degeneration who received nine photobiomodulation sessions using 670 nm LED light. They report that best-corrected visual acuity and several visual field measures improved over the short follow-up, with no adverse effects observed. The authors state that a larger number of patients and longer follow-up are needed.
- Participants
- 10
- Who or what was studied
- Ten patients with dry age-related macular degeneration
- Wavelengths
- 670 nm
- Limits stated in the abstract
- Very small sample of ten patients, short-term follow-up of 16 weeks, and the authors state that a larger number of patients and longer follow-up are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
- Energy density (fluence)
- 4 J/cm2
- Power density (irradiance)
- 50 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Age-related macular degeneration, Light-emitting diode, Retina, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.